Novel Small-Molecule Inhibitor of Apurinic/Apyrimidinic Endonuclease 1 Blocks Proliferation and Reduces Viability of Glioblastoma Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Small-Molecule Inhibitor of Apurinic/Apyrimidinic Endonuclease 1 Blocks Proliferation and Reduces Viability of Glioblastoma Cells

Published:2010-05-26 Issue:3 Volume:334 Page:988-998
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Bapat Aditi,Glass LaTeca S.,Luo Meihua,Fishel Melissa L.,Long Eric C.,Georgiadis Millie M.,Kelley Mark R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas;Bobola;Clin Cancer Res,2001

2. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

3. Base excision repair of ionizing radiation-induced DNA damage in G1 and G2 cell cycle phases

4. The Exonuclease Activity of Human Apurinic/Apyrimidinic Endonuclease (APE1)

5. Mechanisms of human DNA repair: an update

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct regulation of ATM signaling by DNA single-strand breaks and APE1;Nature Communications;2024-08-07

2. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer;Redox Biology;2024-02

3. Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons;Cells;2023-07-20

4. Characterizing inhibitors of human AP endonuclease 1;PLOS ONE;2023-01-18

5. ROS, Redox Regulation, and Anticancer Therapy;Redox Regulation and Therapeutic Approaches in Cancer;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3